Authors:
Tao, T
Skiadopoulos, MH
Davoodi, F
Surman, SR
Collins, PL
Murphy, BR
Citation: T. Tao et al., Construction of a live-attenuated bivalent vaccine virus against human parainfluenza virus (PIV) types 1 and 2 using a recombinant PIV3 backbone, VACCINE, 19(27), 2001, pp. 3620-3631
Citation: Mn. Teng et al., Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo, VIROLOGY, 289(2), 2001, pp. 283-296
Citation: Ka. Sutherland et al., Synergistic effects of gene-end signal mutations and the M2-1 protein on transcription termination by respiratory syncytial virus, VIROLOGY, 288(2), 2001, pp. 295-307
Authors:
Khattar, SK
Yunus, AS
Collins, PL
Samal, SK
Citation: Sk. Khattar et al., Deletion and substitution analysis defines regions and residues within thephosphoprotein of bovine respiratory syncytial virus that affect transcription, RNA replication, and interaction with the nucleoprotein, VIROLOGY, 285(2), 2001, pp. 253-269
Authors:
Bukreyev, A
Belyakov, IM
Berzofsky, JA
Murphy, BR
Collins, PL
Citation: A. Bukreyev et al., Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells, J VIROLOGY, 75(24), 2001, pp. 12128-12140
Authors:
Skiadopoulos, MH
Surman, SR
Riggs, JM
Collins, PL
Murphy, BR
Citation: Mh. Skiadopoulos et al., A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys, J VIROLOGY, 75(21), 2001, pp. 10498-10504
Authors:
Schmidt, AC
McAuliffe, JM
Murphy, BR
Collins, PL
Citation: Ac. Schmidt et al., Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3, J VIROLOGY, 75(10), 2001, pp. 4594-4603
Citation: Em. Carroll et al., Abnormality of calcium channel inhibitor released from fetal membranes in preterm labor, AM J OBST G, 184(3), 2001, pp. 356-362
Authors:
Bailly, JE
McAuliffe, JM
Skiadopoulos, MH
Collins, PL
Murphy, BR
Citation: Je. Bailly et al., Sequence determination and molecular analysis of two strains of bovine parainfluenza virus type 3 that are attenuated for primates, VIRUS GENES, 20(2), 2000, pp. 173-182
Authors:
Tao, T
Davoodi, F
Cho, CJ
Skiadopoulos, MH
Durbin, AP
Collins, PL
Murphy, BR
Citation: T. Tao et al., A live attenuated recombinant chimeric parainfluenza virus (PIV) candidatevaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3, VACCINE, 18(14), 2000, pp. 1359-1366
Authors:
Skiadopoulos, MH
Surman, SR
Durbin, AP
Collins, PL
Murphy, BR
Citation: Mh. Skiadopoulos et al., Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes, VIROLOGY, 272(1), 2000, pp. 225-234
Authors:
Hallak, LK
Collins, PL
Knudson, W
Peeples, ME
Citation: Lk. Hallak et al., Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection, VIROLOGY, 271(2), 2000, pp. 264-275
Authors:
Khattar, SK
Yunus, AS
Collins, PL
Samal, SK
Citation: Sk. Khattar et al., Mutational analysis of the bovine respiratory syncytial virus nucleocapsidprotein using a minigenome system: Mutations that affect encapsidation, RNA synthesis, and interaction with the phosphoprotein, VIROLOGY, 270(1), 2000, pp. 215-228
Authors:
Bailly, JE
McAuliffe, JM
Durbin, AP
Elkins, WR
Collins, PL
Murphy, BR
Citation: Je. Bailly et al., A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is at attenuated in primates, J VIROLOGY, 74(7), 2000, pp. 3188-3195
Authors:
Buchholz, UJ
Granzow, H
Schuldt, K
Whitehead, SS
Murphy, BR
Collins, PL
Citation: Uj. Buchholz et al., Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): Effects on host rangeand evaluation as a live-attenuated HRSV vaccine, J VIROLOGY, 74(3), 2000, pp. 1187-1199
Citation: A. Bukreyev et al., Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo, J VIROLOGY, 74(23), 2000, pp. 11017-11026
Authors:
Schmidt, AC
McAuliffe, JM
Huang, A
Surman, SR
Bailly, JE
Elkins, WR
Collins, PL
Murphy, BR
Skiadopoulos, MH
Citation: Ac. Schmidt et al., Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates, J VIROLOGY, 74(19), 2000, pp. 8922-8929
Authors:
Teng, MN
Whitehead, SS
Bermingham, A
St Claire, M
Elkins, WR
Murphy, BR
Collins, PL
Citation: Mn. Teng et al., Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees, J VIROLOGY, 74(19), 2000, pp. 9317-9321
Authors:
Durbin, AP
Skiadopoulos, MH
McAuliffe, JM
Riggs, JM
Surman, SR
Collins, PL
Murphy, BR
Citation: Ap. Durbin et al., Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy, J VIROLOGY, 74(15), 2000, pp. 6821-6831
Authors:
Bukreyev, A
Whitehead, SS
Prussin, C
Murphy, BR
Collins, PL
Citation: A. Bukreyev et al., Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines, J VIROLOGY, 74(15), 2000, pp. 7151-7157
Authors:
Tao, T
Skiadopoulos, MH
Davoodi, F
Riggs, JM
Collins, PL
Murphy, BR
Citation: T. Tao et al., Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates, J VIROLOGY, 74(14), 2000, pp. 6448-6458
Citation: R. Fearns et al., Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus, J VIROLOGY, 74(13), 2000, pp. 6006-6014